Emphysema COPD Treatment

Cellular Treatment for Emphysema and COPD Offered at the Lung Institute

The Lung Institute is pleased to offer treatment for emphysema and COPD using cellular therapy. Chronic obstructive pulmonary disease (COPD) is a category of lung diseases that includes both emphysema and chronic bronchitis. If you’re living with COPD, you may experience persistent coughing and difficulty breathing, among other symptoms.

Although there is currently no cure for emphysema or COPD, treatment may help improve your quality of life. At the Lung Institute, we offer cellular therapy, which has the potential to promote healing from within the lungs. Our cellular therapy procedure is completed in three steps, which are performed on an outpatient basis. First, we collect a sample of your cells using one of the following two methods:

  • Bone marrow extraction — We can collect your sample from your bone marrow. When compared to peripheral blood, bone marrow tends to contain a greater number of adult cells.
  • Blood draw — We can also extract your sample directly from your bloodstream. This method is less invasive than the one used during bone marrow extraction.

After collecting your sample, we take it to our onsite lab, where we separate the cells contained therein from the rest of the sample. Finally, we return the concentrated cells to your bloodstream. Regardless of whether we collect your sample from your blood or your bone marrow, you won’t have to worry about your system rejecting the concentrated cells, as the cells will be coming directly from your own body.

If you would like more information on how to use cellular therapy for the treatment of emphysema or COPD, please call the Lung Institute today at (800) 729-3065. As the only clinic worldwide that is exclusively focused on treating lung disease, we look forward to helping you breathe easier.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.